Comparative Study of a Smartphone-Linked Self-Monitoring System Versus a Traditional One for Improving Metabolic Control and Compliance to Self-Monitoring of Blood Glucose

Inclusion Criteria: * Type 1 diabetes * Males and females * Age between 14-24 years * Any diabetes duration * Cared for by the diabetes center for at least 1 year * HbA1c ≥ 8% * Basal bolus treatment (any insulin) * Poor compliance with Self-Monitoring of Blood Glucose (less than 30% of the recommended Blood Glucose measurements recorded in the glucose meter in the two previous weeks, i.e. \<16 Blood Glucose measurements in the last two weeks) * Written informed consent obtained from patient or legal representative (for minor) Exclusion Criteria: * Treatment with other insulin regimen or Continuous Subcutaneous Insulin Infusion * Refusal or inability to give informed consent to participate in the study * Patients with short life expectancy * Patients with conditions/concomitant diseases making them non evaluable for the primary efficacy endpoint according to physician's judgment * Requirement for concomitant treatment that could bias primary evaluation * Patients with high likelihood of being unavailable for 6 and/or 12 months visits * Subject is the investigator, sub-investigator, research assistant, pharmacist, study coordinator, other study site staff or relative of study site staff thus considered directly involved in the conduct of the study * Current addition/abuse of alcohol or drugs * Severe visual or dexterity impairment * Patients with any mental condition rendering them unable to understand the nature, scope, and possible consequences of the study * Pregnant or breast-feeding women * Subjects unlikely or unable to comply with the Protocol requirements